| Alex Adams Wertheimer, DO | |
|
709 W Orchard Dr Ste 4, Bellingham, WA 98225-1766 | |
| (360) 318-8800 | |
| Not Available |
| Full Name | Alex Adams Wertheimer |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 709 W Orchard Dr Ste 4, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427440221 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PS0010X | Emergency Medicine - Sports Medicine | OP61124751 (Washington) | Secondary |
| 207P00000X | Emergency Medicine | 61124751 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Skagit Valley Hospital | Mount vernon, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Care Network, Pllc | 0446142046 | 123 |
| Northwest Emergency Physicians Llc | 3476462334 | 186 |
News Archive
The traditional understanding in neuroscience is that tactile sensations from the skin are only assembled to form a complete experience in the cerebral cortex, the most advanced part of the brain.
The National Human Genome Research Institute (NHGRI) has announced it has awarded $2 million to the Genetics and Public Policy Center of the Berman Bioethics Institute at Johns Hopkins University to conduct a public discussion about future potential large U.S. population-based studies examining the roles of genes and environment in human health.
Researchers have identified factors associated with motor, cognitive and mood outcomes after deep-brain stimulation (DBS) of the subthalamic nucleus in a large cohort of patients with Parkinson's disease.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has successfully completed enrollment and treatment of the last patient in its Phase I clinical trial of CUDC-101, Curis' first-in-class HDAC, EGFR and HER2 inhibitor.
› Verified 4 days ago
| Entity Name | North Sound Emergency Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114937919 PECOS PAC ID: 5496646754 Enrollment ID: O20040324000729 |
News Archive
The traditional understanding in neuroscience is that tactile sensations from the skin are only assembled to form a complete experience in the cerebral cortex, the most advanced part of the brain.
The National Human Genome Research Institute (NHGRI) has announced it has awarded $2 million to the Genetics and Public Policy Center of the Berman Bioethics Institute at Johns Hopkins University to conduct a public discussion about future potential large U.S. population-based studies examining the roles of genes and environment in human health.
Researchers have identified factors associated with motor, cognitive and mood outcomes after deep-brain stimulation (DBS) of the subthalamic nucleus in a large cohort of patients with Parkinson's disease.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has successfully completed enrollment and treatment of the last patient in its Phase I clinical trial of CUDC-101, Curis' first-in-class HDAC, EGFR and HER2 inhibitor.
› Verified 4 days ago
| Entity Name | Family Care Network, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427001015 PECOS PAC ID: 0446142046 Enrollment ID: O20040329000176 |
News Archive
The traditional understanding in neuroscience is that tactile sensations from the skin are only assembled to form a complete experience in the cerebral cortex, the most advanced part of the brain.
The National Human Genome Research Institute (NHGRI) has announced it has awarded $2 million to the Genetics and Public Policy Center of the Berman Bioethics Institute at Johns Hopkins University to conduct a public discussion about future potential large U.S. population-based studies examining the roles of genes and environment in human health.
Researchers have identified factors associated with motor, cognitive and mood outcomes after deep-brain stimulation (DBS) of the subthalamic nucleus in a large cohort of patients with Parkinson's disease.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has successfully completed enrollment and treatment of the last patient in its Phase I clinical trial of CUDC-101, Curis' first-in-class HDAC, EGFR and HER2 inhibitor.
› Verified 4 days ago
| Entity Name | Northwest Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235172370 PECOS PAC ID: 3476462334 Enrollment ID: O20041214000892 |
News Archive
The traditional understanding in neuroscience is that tactile sensations from the skin are only assembled to form a complete experience in the cerebral cortex, the most advanced part of the brain.
The National Human Genome Research Institute (NHGRI) has announced it has awarded $2 million to the Genetics and Public Policy Center of the Berman Bioethics Institute at Johns Hopkins University to conduct a public discussion about future potential large U.S. population-based studies examining the roles of genes and environment in human health.
Researchers have identified factors associated with motor, cognitive and mood outcomes after deep-brain stimulation (DBS) of the subthalamic nucleus in a large cohort of patients with Parkinson's disease.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has successfully completed enrollment and treatment of the last patient in its Phase I clinical trial of CUDC-101, Curis' first-in-class HDAC, EGFR and HER2 inhibitor.
› Verified 4 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124270715 PECOS PAC ID: 8325100480 Enrollment ID: O20081224000111 |
News Archive
The traditional understanding in neuroscience is that tactile sensations from the skin are only assembled to form a complete experience in the cerebral cortex, the most advanced part of the brain.
The National Human Genome Research Institute (NHGRI) has announced it has awarded $2 million to the Genetics and Public Policy Center of the Berman Bioethics Institute at Johns Hopkins University to conduct a public discussion about future potential large U.S. population-based studies examining the roles of genes and environment in human health.
Researchers have identified factors associated with motor, cognitive and mood outcomes after deep-brain stimulation (DBS) of the subthalamic nucleus in a large cohort of patients with Parkinson's disease.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has successfully completed enrollment and treatment of the last patient in its Phase I clinical trial of CUDC-101, Curis' first-in-class HDAC, EGFR and HER2 inhibitor.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alex Adams Wertheimer, DO 709 W Orchard Dr Ste 4, Bellingham, WA 98225-1766 Ph: (360) 318-8800 | Alex Adams Wertheimer, DO 709 W Orchard Dr Ste 4, Bellingham, WA 98225-1766 Ph: (360) 318-8800 |
News Archive
The traditional understanding in neuroscience is that tactile sensations from the skin are only assembled to form a complete experience in the cerebral cortex, the most advanced part of the brain.
The National Human Genome Research Institute (NHGRI) has announced it has awarded $2 million to the Genetics and Public Policy Center of the Berman Bioethics Institute at Johns Hopkins University to conduct a public discussion about future potential large U.S. population-based studies examining the roles of genes and environment in human health.
Researchers have identified factors associated with motor, cognitive and mood outcomes after deep-brain stimulation (DBS) of the subthalamic nucleus in a large cohort of patients with Parkinson's disease.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has successfully completed enrollment and treatment of the last patient in its Phase I clinical trial of CUDC-101, Curis' first-in-class HDAC, EGFR and HER2 inhibitor.
› Verified 4 days ago
Ruth M Berner, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-734-5400 Fax: 360-738-6377 | |
Dr. Alexander Duncan Mcbean, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-788-6765 | |
Dr. Martin Watterson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 E Sunset Dr, #145, Pmb 479, Bellingham, WA 98226 Phone: 360-220-1035 | |
Dr. Timothy M Manzo, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1811 Eldridge Ave, Bellingham, WA 98225 Phone: 973-919-1148 | |
James Marcus Pierson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-734-5400 Fax: 360-788-6801 | |
Mark J Zarzycki, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-734-5400 Fax: 360-738-6377 | |
Anna Marie Cedar, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-734-5400 |